Potentiation by 2,2′-pyridylisatogen tosylate of ATP-responses at a recombinant P2Y1 purinoceptor

British Journal of Pharmacology

Volumn 117, Issue 6, 1996, Pages 1111-1118

  King, B F ^c   Dacquet, C ^a   Ziganshin, A U ^c   Weetman, D F ^b   Burnstock, G ^c   Vanhoutte, P M ^a   Spedding, M ^a  

^a INSTITUT DE RECHERCHES SERVIER   (France)

^b UNIVERSITY OF SUNDERLAND   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

2,2 Pyridylisatogen; Adenosine; ATP; Metabotropic purinoceptor; P2 purinoceptor; Purinergic transmission; Recombinant P2Y purinoceptor; Xenopus oocyte

Indexed keywords

2 METHYLTHIOADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ANAZOLENE SODIUM; BENZODIAZEPINE RECEPTOR; CIBACRON BLUE F3GA; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; HISTAMINE H1 RECEPTOR; MEMBRANE RECEPTOR; MU OPIATE RECEPTOR; MUSCARINIC RECEPTOR; PURINE P2Y RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; RADIOLIGAND; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 3 RECEPTOR; SURAMIN; TOLUENESULFONIC ACID DERIVATIVE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CECUM TENIA; CHLORIDE CURRENT; FEMALE; GUINEA PIG; LIGAND BINDING; NONHUMAN; OOCYTE; PRIORITY JOURNAL; RECEPTOR AFFINITY; SMOOTH MUSCLE RELAXATION; XENOPUS;

ADENOSINE TRIPHOSPHATASES; ADENOSINE TRIPHOSPHATE; ANIMALS; CHICKENS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ISATIN; OOCYTES; PATCH-CLAMP TECHNIQUES; RECEPTORS, PURINERGIC P2; RECOMBINANT PROTEINS; XENOPUS;

EID: 0030003638     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb16704.x     Document Type: Article

References (57)

1. ABBRACCHIO, M.P. & BURNSTOCK, G. (1994). Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol. Ther., 64, 445-475.
2. BARNARD, H.A., BURNSTOCK, G. & WEBB, T.E. (1994). G protein-coupled receptors for ATP and other nucleotides: a new receptor family. Trends Pharmacol. Sci., 15, 67-70.
3. 2 purinoceptors: from molecular biology to functional responses. Trends Pharmacol. Sci., 16, 133-139.
4. 3H]-Batrachotoxin-A benzoate binding to voltage sensitive sodium channels; inhibition by the channel blockers tetrodotoxin and saxitoxin. J. Neurosci., 6, 2064-2070.
5. BURNSTOCK, G. (1978). A basis of distinguishing two types of purinergic receptor. In: Cell Membrane Receptors for Drugs and Hormones: a Multidisciplinary Approach, ed. Straub, R.W. & Bolis, L. pp. 107-118. New York: Raven Press.
6. BURNSTOCK, G., CAMPBELL, G., SATCHELL, D. & SMYTHE, A. (1970). Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut. Br. J. Pharmacol., 40, 668-688.
7. 2 purinoceptor. Br. J. Pharmacol., 79, 907-913.
8. 2 purinoceptors? Gen. Pharmacol., 16, 433-440.
9. 2 purinoceptors: heterogeneity with P2X and P2Y subtypes. Drug Devel. Res., 31, 206-219.
10. 50) of an enzymatic reaction. Biochem. Pharmacol., 22, 3099-3018.
11. CUSACK, N.J. & HOURANI, S.M.O. (1990). Structure-activity relationships for adenine nucleotide receptors on mast cells, human platelets, and smooth muscle. In Purines in Cellular Signalling: Targets for New Drugs, ed. Jacobson, K.A., Daly, J.W. & Manganiello, V. pp. 254-259. New York: Springer-Verlag.
12. DALZIEL, H.H. & WESTFALL, D.P. (1994). Receptors for adenine nucleotides and nucleosides: subclassification, distribution, and molecular characterization. Pharmacol. Rev., 46, 449-466.
13. DEAN, D.M. & DOWNIE, J.W. (1978). Contribution of adrenergic and "purinergic" neurotransmission to contraction in rabbit detrusor. J. Pharmacol. Exp. Ther., 207, 431-445.
14. 2U purinoceptors. J. Biol. Chem., 270, 4185-4188.
15. FILTZ, T.M., LI, Q., BOYER, J.L., NICHOLAS, R.A. & HARDEN, T.K. (1994). Expression of a cloned P2Y purinergic receptor that couples to phospholipase C. Mol. Pharmacol., 46, 8-15.
16. FISKE, C.H. & SUBBAROW, Y. (1925). The colorimetric determination of phosphorus. J. Biol. Chem., 66, 375-400.
17. FOSTER, H.E., HOPPER, M., SPEDDING, M., SWEETMAN, A.J. & WEETMAN, D.F. (1978). Antagonism of the inhibitory effects of adenosine 5′-triphosphate on the isolated taenia of the guinea-pig caecum: structure-activity relationships within a series of isatogen derivatives. Br. J. Pharmacol., 63, 309-314.
18. GIBSON, A. & TUCKER, J.F. (1982). The effects of vasoactive intestinal polypeptide and of adenosine 5′-triphosphate on the isolated anococcygeus muscle of the mouse. Br. J. Pharmacol., 77, 97-103.
19. GLOSSMANN, H., HORNUNG, R. & PRESEK, P. (1980). The use of ligand binding for the characterization of alpha-adrenoceptors. J. Cardiovasc. Pharmacol., 2 (suppl.3), S303-S324
20. ++ channels. Positive allosteric heterotropic regulation by d-cis-diltiazem is associated with apparent channel oligomer dissociation. FEBS Lett., 157, 63-69.
21. 3H]-8-Hydroxy-2-(di-n-propylamino)tetralin binding to pre and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain. J. Neurochem., 44, 1685-1696.
22. HENDERSON, D.J., ELLIOT, D.G., WEBB, T.E. & DAINTY, I.A. (1995). Cloning and characterisation of a bovine P2Y purinoceptor cDNA. Biochem. Biophys. Res. Commun., 211, 211-218.
23. 1 dopamine receptors in rat striatum. Eur. J. Pharmacol., 121, 31-38.
24. 1 receptors in the brain of the guinea-pig and the rat: differences in ligand binding properties and regional distribution. Br. J. Pharmacol., 68, 687-696.
25. HILLAIRE-BUYS, D., CHAPAL, J., PETIT, P. & LOUBATIERES, M.M. (1991). Dual regulation of pancreatic vascular tone by P2X and P2Y purinoceptor subtypes. Eur. J. Pharmacol., 199, 309-314.
26. HOOPER, M. & ROBERTSON, J.W. (1971). Isatogens. VIII: The reaction of 2(2-pyridyl)isatogen with leucine and valine. Tetrahedron Lett., 2139-2140.
27. 125I] iodocyanopindolol. Eur. J. Pharmacol., 118, 1-12.
28. HU, P., LINGREN, E., JACOBSON, K.A. & FREDHOLM, B. (1987). Interaction of dihydropyridine calcium channel agonists and antagonists with adenosine receptor. Pharmacol. Toxicol., 61, 121-125.
29. KAZIC, T. & MILOSAVLJEVIC, D. (1977). Influence of pyridylisatogen tosylate on contractions produced by ATP and by purinergic stimulation in the terminal ileum of the guinea-pig. J. Pharm. Pharmacol., 29, 542-545.
30. 2y1 purinoceptor. Br. J. Pharmacol., 113, 60P.
31. 2 receptors in the rat brain. Biochem. Pharmacol., 34, 2251-2259.
32. LEON, C., VIAL, C., CAZENAVE, J.P. & GACHET, C. (1995). Cloning and sequencing of a human endothelial P2Y1 purinoceptor. Gene, (in press).
33. 3H-ligand for serotonin-2 receptors binding sites. Mol. Pharmacol., 21, 301-314.
34. MCEWEN, L.M. (1956). The effect on the isolated rabbit heart of vagal stimulation and its modulation by cocaine, hexamethonium and ouabain. J. Physiol., 131, 678-689.
35. MÖLHER, H., BURKARD, W.P., KELLER, H.H., RICHARDS, J.G. & HAEFELY, W. (1981). Benzodiazepine antagonist Ro 15-1788: Binding characteristics and interaction with drug induced changes in dopamine turnover and cerebellar GMP levels. J. Neurochem., 37, 714-722.
36. MORITOKI, H., TAKEI, M., KASAI, T., MATSUMARA, Y. & ISHIDA, Y. (1979). Possible involvement of prostaglandins in the action of ATP on guinea-pig uterus. J. Pharmacol. Exp. Ther., 211, 104-111.
37. 3 binding sites in rat brain cortical membranes. Biochem. Pharmacol., 38, 1693-1695.
38. RATTAN, S. & GOYAL, R.K. (1980). Evidence against purinergic inhibitory nerves in the vagal pathway to the oppossum lower esophageal sphincter. Gastroenterol., 78, 898-904.
39. alpha-2A adrenergic receptors and other populations of alpha-2 adrenergic subtypes. J. Pharmacol. Exp. Ther., 270, 946-957.
40. RIKIMARU, A., FUKUSHI, Y. & SUZUKI, T. (1971). Effects of imidazole and phentolamine on the relaxant responses of guinea-pig taenia coli to transmural stimulation and to adenosine triphosphate. Tokohu J. Exp. Med., 105, 199-200.
41. ROSKOSKI Jr, R., GUTHRIE Jr, R., ROSKOSKI, L.M. & ROSSOWSKI, W. (1985). Degradation of rat brain cholinergic muscarinic receptors in vitro: enhancement by agonist and inhibition by antagonists. J. Neurochem., 45, 1096-1100.
42. SATCHELL, D., BURNSTOCK, G. & DANN, P. (1973). Antagonism of the effects of purinergic nerve stimulation and exogenously applied ATP on the guinea-pig taenia coli by 2-substituted imidazolines and related compounds. Eur. J. Pharmacol., 23, 264-269.
43. SATCHELL, D.G., LYNCH, A., BOURKE, P.M. & BURNSTOCK, G. (1972). Potentiation of the effects of exogenously applied ATP and purinergic nerve stimulation on the guinea-pig taenia coli by dipyridamole and hexobendine. Eur. J. Pharmacol., 19, 343-350.
44. SHARIF, N.A. & HUGHES, J. (1989). Discrete mapping of brain mu and delta opioid receptors using selective peptides: quantitative autoradiography, species differences and comparison with kappa receptors. Peptides, 10, 499-522.
45. SIMON, J., WEBB, T.E., KING, B.F., BURNSTOCK, G. & BARNARD, E.A. (1995). Characterisation of a recombinant P2Y purinoceptor. Eur. J. Pharmacol. (Mol. Pharmacol.), 291, 281-289.
46. 2 purinergic responses than Reactive blue 2 (Cibacron blue 3GA) in rat parotid acinar cells. Biochem. Biophys. Res. Commun., 165, 1279-1285.
47. SPEDDING, M. (1977). A modified guinea-pig stomach preparation. Br. J. Pharmacol., 63, 408-409P.
48. SPEDDING, M., DACQUET, C., BILLINGTON, D., WEETMAN, D.F., KING, B.F. & BURNSTOCK, G. (1994). 2,2′-Pyridylisatogen, an ATP antagonist, revisited. Br. J. Pharmacol., 113, 59P.
49. SPEDDING, M., SWEETMAN, A.J. & WEETMAN, D.F. (1975). Antagonism of adenosine 5'-triphosphate-induced relaxation by 2,2′-pyridylisatogen in the taenia of guinea pig caecum. Br. J. Pharmacol., 53, 575-583.
50. SPEDDING, M. & WEETMAN, D.F. (1976). Identification of separate receptors for adenosine and adenosine 5′-triphosphate in causing relaxations of the isolated taenia of the guinea-pig caecum. Br. J. Pharmacol., 57, 305-310.
51. SPEDDING, M. & WEETMAN, D.F. (1978a). The problems associated with the use of 2,2′-pyridylisatogen tosylate in evaluating the allegedly purinergic innervation of peripheral organs. J. Pharm. Pharmacol., 30, 335-336.
52. SPEDDING, M. & WEETMAN, D.F. (1978b). The mechanism of the relaxant effect of 2,2′-pyridylisatogen on the isolated taenia of the guinea-pig caecum. Br. J. Pharmacol., 63, 659-664.
53. SU, C. (1978). Purinergic inhibition of adrenergic transmission in rabbit blood vessels. J. Pharmacol. Exp. Ther., 204, 351-361.
54. VAN ROSSUM, J.M. (1963). Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch. Int. Pharmacodyn. Ther., 143, 299-330.
55. WEBB, T.E., SIMON, J., KRISHEK, B.J., BATESON, A.N., SMART, T.G., KING, B.F., BURNSTOCK, G. & BARNARD, E.A. (1993). Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett., 324, 219-225.
56. ZIGANSHIN, A.U., ZIGANSHINA, L.E., KING, B.F. & BURNSTOCK, G. (1994). Breakdown of ATP and other common nucleotides by two ecto-ATPases of Xenopus oocyte. J. Physiol., 480, 66P.
57. ZIGANSHIN, A.U., ZIGANSHINA, L.E., KING, B.F. & BURNSTOCK, G. (1995). Characteristics of ecto-ATPase of Xenopus oocytes and the inhibitory actions of suramin on ATP breakdown. Pflüger's Archiv., 429, 412-418.